The New “Price” of U.S. Health Care: The Future of Value-based Reimbursement Under President-elect Trump and Tom Price

by Carlton Fields
Contact

Carlton Fields

[co-author: Gail Jankowski - Law Clerk]

The total U.S. health care expenditure was $3.2 trillion in 2015, and is projected to grow to nearly $5.6 trillion by 2025.(1) As our nation’s cost of care rises, both Democrats and Republicans recognize the overwhelming need to control health care expenses while maintaining and improving quality of care. Under the Obama administration, the Department of Health and Human Services (HHS) pledged that by 2018, half of traditional Medicare payments would be based on value-based payment models that incentivize high quality, low cost care as opposed to payments based upon volume.(2)

In theory, a value-based payment scheme that transforms how health care is delivered by rewarding quality improvement, focusing on patient health outcomes, and reducing unnecessary costs, is non-partisan. Yet, the ways in which Republicans and Democrats seek to attain the goal of high quality, low cost care differ.

Value-based Reimbursement Under President Obama

Over the last few years, the CMS Innovation Center (CMMI) has been a key component in the implementation of President Obama’s Affordable Care Act (ACA). Created by Section 3021 of the ACA, CMMI’s stated purpose is to innovate and test new payment models that would lower cost and improve quality for individuals who receive Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) benefits. Through Section 3021 of the ACA, Congress provides the Secretary of HHS with the authority to expand innovative payment models through rulemaking, including the ability to test these models on a national basis. Thus, the ACA allowed the Obama administration to test value-based reimbursement models via rulemaking.

Throughout President Obama’s term, CMMI has implemented several programs including Accountable Care Organizations and episode-based payment initiatives (i.e., bundled payments, gainsharing, and comprehensive joint replacement programs). CMMI also

plays a key role in the Quality Payment Program, created as part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), through which clinicians may earn incentive payments by participating in Advanced Alternative Payment Models. Payment methodologies that qualify as Advanced Alternative Payment Models under MACRA are determined by CMMI.

Although most CMMI payment models under President Obama have been voluntary, several recent CMMI initiatives mandate participation. One such initiative is the Comprehensive Joint Replacement program, which required certain hospitals to share a single bundled payment to cover the cost of certain joint replacement procedures, including in-patient and post-operative care. A similar mandatory project is set to take effect soon for certain cardiac care episodes. In both mandatory programs, hospitals are required to assume downside risk, which means they must pay Medicare if costs exceed a set threshold. The implementation of these mandatory value-based payment initiatives has sparked increased criticism of CMMI. Republicans have argued that HHS is overreaching its power by mandating these payment programs.

Value-based Reimbursement Under President-elect Trump and Rep. Price

President-elect Donald Trump’s selection of Representative Tom Price (R-GA), an outspoken critic of CMMI, as his nominee for incoming HHS Secretary came on the heels of the Centers for Medicare & Medicaid Services’ (CMS’) release of the much- anticipated MACRA final rule, which, as part of its greater effort to advance CMS toward value-based payments, transitions Medicare away from a volume-based fee-for-service system to a value-based system.

Back in September, Price joined fellow GOP lawmakers to ask CMMI to “stop experimenting with Americans’ health, and cease all current and future planned mandatory initiatives.”(3) Price wrote, “CMMI’s mandatory demonstrations could potentially harm patients and providers because CMMI is making participation in the demonstrations mandatory, rather than voluntary, before we know how they will affect access to care, quality, and outcomes. CMMI has overstepped its authority and there are real-life implications—both medical and constitutional. That’s why we’re demanding CMMI cease all current and future mandatory models.”(4) The letter continued: “As a result, Medicare providers and their patients are blindly being forced into high-risk government-dictated reforms with unknown impacts […] Any true medical experiment requires patients' consent. However, patients residing in an affected geographical area will have no choice about their participation.”

Price is not alone in believing that the ACA gives the head of HHS too much authority to create and expand Medicare and Medicaid payment models. In a letter to Andy Slavitt, Acting CMS Administrator, the American Hospital Association also expressed disapproval of CMS’ proposal to expand these mandatory bundled payment models.(5)

Throughout his campaign, President-elect Trump reaffirmed his disdain for the ACA and pledged to repeal it. President-elect Trump’s website addressed the issue of health care reform as follows:

“A Trump Administration will work with Congress to repeal the ACA and replace it with a solution that includes Health Savings Accounts (HSAs), and returns the historic role in regulating health insurance to the States. The Administration’s goal will be to create a patient-centered healthcare system that promotes choice, quality and affordability with health insurance and healthcare, and take any needed action to alleviate the burdens imposed on American families and businesses by the law…. With the assistance of Congress and working with the States, as appropriate, the Administration will act to: […] Modernize Medicare, so that it will be ready for the challenges with the coming retirement of the Baby Boom generation – and beyond.”(6)

Yet, the question remains: How would repeal of the ACA affect the shift to value-based reimbursement?

With Republican control of the presidency, House, and Senate, the incoming Trump administration is likely to pursue solutions that decrease the role of the federal government in defining regulatory requirements and mandatory programs, and increase the role of the legislature, states, and private sector.

Some have speculated that President-elect Trump's stated intention to “repeal and replace” the ACA, regardless of whether it comes to fruition, is unlikely to fully eliminate the American health care system’s steady movement toward value-based payment.(7) However, it is undeniable that the ACA’s full repeal would effectively cripple many of the current value-based payment initiatives and mandatory programs, especially given that CMMI derives both its mission and funding from the ACA.

As the transition from one administration to another approaches, health policy experts are making predictions. Joseph Antos, a fellow at the conservative American Enterprise Institute, has observed that under the Obama administration there has been “a fundamental shift from Congress to the executive branch in the ability to set policies for some of our nation's most important and costly public programs.”(8) Antos further stated in an interview, “I can’t imagine a Trump administration saying we want the bureaucrats to decide on the health care your grandmother is going to get […] Anything that is that much of a marquee issue absolutely has to go through Congress.”(9) However, Blair Childs, senior vice president of the health care improvement company Premier, projected in an interview that “calmer heads” would likely prevail when Trump assumes the presidency, and that “CMMI will in the end survive” in order to meet the need of a “mechanism to test and scale new models in fee-for-service Medicare.”(10) In early December, at a summit on population health strategy under the new administration, former HHS Secretary Michael Leavitt stated, “CMMI will be challenged, but the analytics it provides are important to maintain […] we need to find the balance between provider readiness and the speed to change between providers and payers […] the GOP is not in lockstep […] the bottom line is we don’t know.”(11)

To date, it is certain that the shift from volume-based payment to value-based payment has taken considerable resources, not only on the part of government, but also on the part of providers. The future of value-based payment is unknown; but, a full repeal of the ACA would have dramatic consequences.

Copyright 2016, American Health Lawyers Association, Washington, DC. Reprint permission granted.

 

 

 

1 Centers for Medicare & Medicaid Services: National Health Expenditures 2015 Highlights, https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and- Reports/NationalHealthExpendData/downloads/highlights.pdf.
2 Centers for Medicare & Medicaid Services: Health Care Payment Learning And Action Network, https://innovation.cms.gov/initiatives/Health-Care-Payment-Learning-and-Action-Network/.
3
U.S. Representative Tom Price: Price, Boustany, Paulsen Lead Letter to Stop CMMI’s Overreach (Sept. 29, 2016).
4 Letter from U.S. Congressmen Tom Price, MD, Charles W. Boustany, Jr., MD, and Erik Paulsen to Centers for Medicare & Medicaid Services Administrators Andrew Slavitt and Patrick Conway, MD (Sept. 29, 2016), available at http://tomprice.house.gov/sites/tomprice.house.gov/files/assets/September%2029%2C%202016%20CMMI% 20Letter.pdf/.
5 See Letter from Thomas P. Nickels to Andy Slavitt, (Sept. 6, 2016), available at http://www.aha.org/advocacy-issues/letter/2016/160906-cl-opps-asc-quality.pdf.
6
President Elect Donald J. Trump Transition Website: Healthcare (visited Dec. 9, 2016) https://www.greatagain.gov/policy/healthcare.html, available at https://greatagain.gov/healthcare- 396f348e51ef#.9stbc6u3m.
7 See Elizabeth Whitman, Will value-based payment initiatives continue under Trump?, MODERN HEALTHCARE, (Nov. 11, 2016) http://www.modernhealthcare.com/article/20161111/MAGAZINE/161109907.
8
Shannon Muchmore, GOP May Try to Hobble CMS Innovation Center, MODERN HEALTHCARE (Nov. 7, 2016), http://www.modernhealthcare.com/article/20161107/NEWS/161109942.
9
Julie Appleby, Obamacare's Test Kitchen For Payment Experiments Faces An Uncertain Future, NPR (Nov. 30, 2016), http://www.npr.org/sections/health-shots/2016/11/30/503863311/health-law-s-test-kitchen-for-payment-changes-could-offer-tool-for-gop-ideas.
10 Whitman, supra note 7.
11 Greg Fulton, Letter from Washington: The Path Forward for Value-based Care, PHILIPS WELLCENTIVE (Dec. 5, 2016).

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Carlton Fields | Attorney Advertising

Written by:

Carlton Fields
Contact
more
less

Carlton Fields on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.